Patent Assignment
Reel/Frame 050362/0445
Security Interest
Recorded: 2019-09-12
Pages: 17
Assignor
XERIS PHARMACEUTICALS, INC.
Executed: 2019-09-10
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
133 NORTH FAIRFAX STREET, ATTN: LEGAL DEPARTMENT, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(25)
Precipitation Resistant Small Molecule Drug Formulations
PCT:
PCT/US2018/035473 ↗
Methods for Treating Congenital Hyperinsulinism
PCT:
PCT/US2018/042197 ↗
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
PCT:
PCT/US2018/067294 ↗
Treatment of Post-Bariatric Hypoglycemia Using Mini-Dose Stable Glucagon
PCT:
PCT/US2019/014815 ↗
Intracutaneous Injection
Intracutaneous Paste Composition
Stable Formulations for Parenteral Injection of Peptide Drugs
Methods for Rapidly Treating Severe Hypoglycemia
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Stable Formulations for Parenteral Injection of Peptide Drugs
Stable Formulations for Parenteral Injection of Peptide Drugs
Stable Formulations for Parenteral Injection of Peptide Drugs
Pastes for Injection of a Therapeutic Agent
Formulations for the Treatment of Diabetes
Compositions for Rapidly Treating Severe Hypoglycemia
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Stable Formulations for Parenteral Injection of Peptide Drugs
Stable Peptide Formulations and Methods for Preparation
Application:
15/117,016 →
Publication:
US 2017/0007675
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Syringes, Kits, and Methods for Intracutaneous and/or Subcutaneous Injection of Pastes
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Use of Low Dose Glucagon
Application:
15/735,052 →
Publication:
US 2019/0083578
Methods for Producing Stable Therapeutic Glucagon Formulations in Aprotic Polar Solvents
Precipitation Resistant Small Molecule Drug Formulations
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Application:
62/855,134 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 7, 2011
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS INC.
Reel/Frame 025755/0655 →
Assignment of Assignor's Interest
May 31, 2012
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 028299/0946 →
Assignment of Assignor's Interest
Jul 16, 2013
From: PRESTRELSKI, STEVEN J.; NEWSWANGER, BRETT
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 030802/0465 →
Assignment of Assignor's Interest
Sep 26, 2013
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 031287/0727 →
Assignment of Assignor's Interest
Mar 19, 2014
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 032478/0154 →
Assignment of Assignor's Interest
Nov 18, 2014
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 034201/0313 →
Assignment of Assignor's Interest
Dec 30, 2014
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 034602/0298 →
Assignment of Assignor's Interest
Feb 15, 2016
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 037733/0532 →
Assignment of Assignor's Interest
May 11, 2016
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 038542/0989 →
Assignment of Assignor's Interest
Jun 9, 2016
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 038855/0303 →
Assignment of Assignor's Interest
Jan 12, 2017
From: PRESTRELSKI, STEVEN J.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 040956/0823 →
Assignment of Assignor's Interest
Apr 20, 2018
From: PRESTRELSKI, STEVEN; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 045595/0958 →
Assignment of Assignor's Interest
Feb 27, 2019
From: DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 048460/0152 →
Assignment of Assignor's Interest
Mar 7, 2019
From: PATTI, MARY ELIZABETH
To: JOSLIN DIABETES CENTER
Reel/Frame 048535/0539 →
Assignment of Assignor's Interest
Mar 7, 2019
From: NEWSWANGER, BRETT; PRESTRELSKI, STEVEN J.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 048535/0476 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0700 →
Assignment of Assignor's Interest
Nov 21, 2024
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 069356/0461 →